ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Wave Life Sciences Ltd

Wave Life Sciences Ltd (WVE)

6.39
0.19
(3.06%)
Closed June 12 4:00PM
6.39
0.00
( 0.00% )
Pre Market: 7:28AM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
6.39
Bid
6.39
Ask
6.51
Volume
-
0.00 Day's Range 0.00
3.45 52 Week Range 7.67
Market Cap
Previous Close
6.39
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
591,046
Shares Outstanding
122,284,139
Dividend Yield
-
PE Ratio
-13.59
Earnings Per Share (EPS)
-0.47
Revenue
115.18M
Net Profit
-57.51M

About Wave Life Sciences Ltd

WAVE Life Sciences Ltd is a preclinical biopharmaceutical company based in Singapore. It owns a diverse pipeline of nucleic acid therapeutics meant to address rare genetic diseases related to the central nervous system, muscles, eyes, liver, and skin. Its nucleic acid therapeutics target genetic def... WAVE Life Sciences Ltd is a preclinical biopharmaceutical company based in Singapore. It owns a diverse pipeline of nucleic acid therapeutics meant to address rare genetic diseases related to the central nervous system, muscles, eyes, liver, and skin. Its nucleic acid therapeutics target genetic defects to either reduce the expression of disease-promoting proteins or transform the production of dysfunctional mutant proteins into the production of functional proteins. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Singapore, Sgp
Founded
1970
Wave Life Sciences Ltd is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker WVE. The last closing price for Wave Life Sciences was $6.39. Over the last year, Wave Life Sciences shares have traded in a share price range of $ 3.45 to $ 7.67.

Wave Life Sciences currently has 122,284,139 shares outstanding. The market capitalization of Wave Life Sciences is $781.40 million. Wave Life Sciences has a price to earnings ratio (PE ratio) of -13.59.

WVE Latest News

Wave Life Sciences Announces Upcoming Presentations Highlighting Novel siRNA Program in Obesity and Leadership in RNA Editing

Presentation at the Obesity & Weight Loss Drug Development Summit to review Real World Evidence for the GLP-1 class and the opportunity for Wave’s INHBE program as a best-in-class approach for...

Wave Life Sciences to Present at 2024 Jefferies Global Healthcare Conference

CAMBRIDGE, Mass., May 30, 2024 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to...

Wave Life Sciences Reports First Quarter 2024 Financial Results and Provides Business Update

RestorAATion-2 clinical trial of WVE-006 in AATD patients underway; expected proof-of-mechanism data in patients with AATD remains on track for 2024 INHBE program for obesity expected clinical...

Wave Life Sciences Announces Appointment of Dr. Erik Ingelsson as Chief Scientific Officer

CAMBRIDGE, Mass., May 09, 2024 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to...

Wave Life Sciences to Present at 2024 RBC Capital Markets Global Healthcare Conference

CAMBRIDGE, Mass., May 07, 2024 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to...

Wave Life Sciences First Quarter 2024 Financial Results Scheduled for May 9, 2024

CAMBRIDGE, Mass., May 02, 2024 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.162.568218298566.236.44025.574669166.11435225CS
40.58.488964346355.896.635.575522716.19124867CS
120.182.898550724646.216.634.645910465.82808705CS
261.9543.91891891894.447.673.57852115.43427873CS
522.1851.78147268414.217.673.456081685.18520798CS
156-0.92-12.5854993167.317.671.165029544.53410335CS
260-16.71-72.337662337723.139.991.165735897.44243197CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
NCINeo Concept International Group Holdings Ltd
$ 1.05
(60.89%)
12.55M
LGHLWLion Group Holding Ltd
$ 0.0098
(44.12%)
1.05M
LGVNLongeveron Inc
$ 2.40
(32.60%)
7.19M
BRTXBioRestorative Therapies Inc
$ 1.66
(22.96%)
2.09M
DUOFangDD Network Group Ltd
$ 0.7369
(20.80%)
3.41M
IONMAssure Holdings Corporation
$ 0.2496
(-51.35%)
857.72k
CARACara Therapeutics Inc
$ 0.501
(-26.27%)
43.25k
APYXApyx Medical Corporation
$ 1.24
(-20.01%)
243
NAVINavient Corporation
$ 11.70
(-19.14%)
1
MTENMingteng International Corporation Inc
$ 3.90
(-18.58%)
2
NCINeo Concept International Group Holdings Ltd
$ 1.05
(60.89%)
12.55M
LGVNLongeveron Inc
$ 2.40
(32.60%)
7.19M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
$ 8.51
(12.72%)
5.33M
DUOFangDD Network Group Ltd
$ 0.7369
(20.80%)
3.41M
TSLATesla Inc
$ 188.84
(6.51%)
2.97M

Your Recent History

Delayed Upgrade Clock